Skip to content
Back to meeting Original
LACOG - Latin American Cooperative Oncology Group· @LACOG_group · X·· 2 days agoScore45

#LACOG

Body · original

On October 23, LACOG investigator Dr. Gustavo Werutsky presented patient-reported outcomes (PROs) from the phase III lidERA trial at ESMO Congress 2026 in Madrid, highlighting quality of life and treatment tolerability in early breast cancer.

#LACOG #ESMO2026

30 views · 0 likes · 0 reposts · 0 replies

Conference abstracts
2259PNCT04558866NCT04558866NCT04558866matched by Metastatic prostate cancer

Genomic biomarkers of response to extreme bipolar androgen therapy (BAT) alternating darolutamide in metastatic castration-resistant prostate cancer: An ancillary biomarker analysis of the ExBAT/LACOG 0620 trial

https://esmocongress.esmo.org

Source: LACOG - Latin American Cooperative Oncology Group · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.